Literature DB >> 27112409

Structural Study of a Flexible Active Site Loop in Human Indoleamine 2,3-Dioxygenase and Its Functional Implications.

Lucía Álvarez1,2, Ariel Lewis-Ballester3, Adrián Roitberg4, Darío A Estrin1,2, Syun-Ru Yeh3, Marcelo A Marti5,6, Luciana Capece1,2.   

Abstract

Human indoleamine 2,3-dioxygenase catalyzes the oxidative cleavage of tryptophan to N-formyl kynurenine, the initial and rate-limiting step in the kynurenine pathway. Additionally, this enzyme has been identified as a possible target for cancer therapy. A 20-amino acid protein segment (the JK loop), which connects the J and K helices, was not resolved in the reported hIDO crystal structure. Previous studies have shown that this loop undergoes structural rearrangement upon substrate binding. In this work, we apply a combination of replica exchange molecular dynamics simulations and site-directed mutagenesis experiments to characterize the structure and dynamics of this protein region. Our simulations show that the JK loop can be divided into two regions: the first region (JK loop(C)) displays specific and well-defined conformations and is within hydrogen bonding distance of the substrate, while the second region (JK loop(N)) is highly disordered and exposed to the solvent. The peculiar flexible nature of JK loop(N) suggests that it may function as a target for post-translational modifications and/or a mediator for protein-protein interactions. In contrast, hydrogen bonding interactions are observed between the substrate and Thr379 in the highly conserved "GTGG" motif of JK loop(C), thereby anchoring JK loop(C) in a closed conformation, which secures the appropriate substrate binding mode for catalysis. Site-directed mutagenesis experiments confirm the key role of this residue, highlighting the importance of the JK loop(C) conformation in regulating the enzymatic activity. Furthermore, the existence of the partially and totally open conformations in the substrate-free form suggests a role of JK loop(C) in controlling substrate and product dynamics.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27112409      PMCID: PMC5450165          DOI: 10.1021/acs.biochem.6b00077

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  61 in total

1.  Trp-cage: folding free energy landscape in explicit water.

Authors:  Ruhong Zhou
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-27       Impact factor: 11.205

2.  Structure and transcription of the Drosophila melanogaster vermilion gene and several mutant alleles.

Authors:  L L Searles; R S Ruth; A M Pret; R A Fridell; A J Ali
Journal:  Mol Cell Biol       Date:  1990-04       Impact factor: 4.272

3.  Evidence for a ferryl intermediate in a heme-based dioxygenase.

Authors:  Ariel Lewis-Ballester; Dipanwita Batabyal; Tsuyoshi Egawa; Changyuan Lu; Yu Lin; Marcelo A Marti; Luciana Capece; Dario A Estrin; Syun-Ru Yeh
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-29       Impact factor: 11.205

Review 4.  Redox reactions related to indoleamine 2,3-dioxygenase and tryptophan metabolism along the kynurenine pathway.

Authors:  S R Thomas; R Stocker
Journal:  Redox Rep       Date:  1999       Impact factor: 4.412

Review 5.  Trial watch: IDO inhibitors in cancer therapy.

Authors:  Erika Vacchelli; Fernando Aranda; Alexander Eggermont; Catherine Sautès-Fridman; Eric Tartour; Eugene P Kennedy; Michael Platten; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2014-12-15       Impact factor: 8.110

Review 6.  Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism.

Authors:  M W Taylor; G S Feng
Journal:  FASEB J       Date:  1991-08       Impact factor: 5.191

7.  Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase.

Authors:  Catherine Uyttenhove; Luc Pilotte; Ivan Théate; Vincent Stroobant; Didier Colau; Nicolas Parmentier; Thierry Boon; Benoît J Van den Eynde
Journal:  Nat Med       Date:  2003-09-21       Impact factor: 53.440

Review 8.  IDO expression by dendritic cells: tolerance and tryptophan catabolism.

Authors:  Andrew L Mellor; David H Munn
Journal:  Nat Rev Immunol       Date:  2004-10       Impact factor: 53.106

9.  Crystal structure of human indoleamine 2,3-dioxygenase: catalytic mechanism of O2 incorporation by a heme-containing dioxygenase.

Authors:  Hiroshi Sugimoto; Shun-ichiro Oda; Takashi Otsuki; Tomoya Hino; Tadashi Yoshida; Yoshitsugu Shiro
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-13       Impact factor: 11.205

10.  POVME 2.0: An Enhanced Tool for Determining Pocket Shape and Volume Characteristics.

Authors:  Jacob D Durrant; Lane Votapka; Jesper Sørensen; Rommie E Amaro
Journal:  J Chem Theory Comput       Date:  2014-09-29       Impact factor: 6.006

View more
  9 in total

1.  Conformational Plasticity in Human Heme-Based Dioxygenases.

Authors:  Khoa N Pham; Ariel Lewis-Ballester; Syun-Ru Yeh
Journal:  J Am Chem Soc       Date:  2020-12-29       Impact factor: 15.419

Review 2.  Abnormal kynurenine pathway of tryptophan catabolism in cardiovascular diseases.

Authors:  Ping Song; Tharmarajan Ramprasath; Huan Wang; Ming-Hui Zou
Journal:  Cell Mol Life Sci       Date:  2017-03-17       Impact factor: 9.261

Review 3.  Different Mechanisms of Catalytic Complex Formation in Two L-Tryptophan Processing Dioxygenases.

Authors:  Karin Nienhaus; G Ulrich Nienhaus
Journal:  Front Mol Biosci       Date:  2018-01-04

4.  Structural insights into substrate and inhibitor binding sites in human indoleamine 2,3-dioxygenase 1.

Authors:  Ariel Lewis-Ballester; Khoa N Pham; Dipanwita Batabyal; Shay Karkashon; Jeffrey B Bonanno; Thomas L Poulos; Syun-Ru Yeh
Journal:  Nat Commun       Date:  2017-11-22       Impact factor: 14.919

Review 5.  A short history of heme dioxygenases: rise, fall and rise again.

Authors:  Emma L Raven
Journal:  J Biol Inorg Chem       Date:  2016-12-01       Impact factor: 3.358

6.  Immune-modulating enzyme indoleamine 2,3-dioxygenase is effectively inhibited by targeting its apo-form.

Authors:  Micah T Nelp; Patrick A Kates; John T Hunt; John A Newitt; Aaron Balog; Derrick Maley; Xiao Zhu; Lynn Abell; Alban Allentoff; Robert Borzilleri; Hal A Lewis; Zeyu Lin; Steven P Seitz; Chunhong Yan; John T Groves
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-12       Impact factor: 11.205

Review 7.  Advances in indoleamine 2,3-dioxygenase 1 medicinal chemistry.

Authors:  Alice Coletti; Francesco Antonio Greco; Daniela Dolciami; Emidio Camaioni; Roccaldo Sardella; Maria Teresa Pallotta; Claudia Volpi; Ciriana Orabona; Ursula Grohmann; Antonio Macchiarulo
Journal:  Medchemcomm       Date:  2017-05-16       Impact factor: 3.597

8.  Temporary Intermediates of L-Trp Along the Reaction Pathway of Human Indoleamine 2,3-Dioxygenase 1 and Identification of an Exo Site.

Authors:  Manon Mirgaux; Laurence Leherte; Johan Wouters
Journal:  Int J Tryptophan Res       Date:  2021-12-15

Review 9.  One Key and Multiple Locks: Substrate Binding in Structures of Tryptophan Dioxygenases and Hydroxylases.

Authors:  Andrea Mammoli; Alessandra Riccio; Elisa Bianconi; Alice Coletti; Emidio Camaioni; Antonio Macchiarulo
Journal:  ChemMedChem       Date:  2021-07-16       Impact factor: 3.466

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.